The effectiveness and safety of Risankizumab in pediatric patients with medically refractory inflammatory bowel disease
- DOI
- 10.1002/jpn3.70534
- Published
- 2026-08-13
- Container
- Journal of Pediatric Gastroenterology and Nutrition
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/jpn3.70534,
title = {The effectiveness and safety of Risankizumab in pediatric patients with medically refractory inflammatory bowel disease},
author = {Michael P. Duggan and Evangelos D. Katsanos and Hassan Hamandi},
year = {2026},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
doi = {10.1002/jpn3.70534},
url = {https://doi.org/10.1002/jpn3.70534}
}RIS
TY - JOUR TI - The effectiveness and safety of Risankizumab in pediatric patients with medically refractory inflammatory bowel disease AU - Michael P. Duggan AU - Evangelos D. Katsanos AU - Hassan Hamandi PY - 2026 JO - Journal of Pediatric Gastroenterology and Nutrition DO - 10.1002/jpn3.70534 UR - https://doi.org/10.1002/jpn3.70534 ER -
APA
Duggan, M. P., Katsanos, E. D., & Hamandi, H. (2026). The effectiveness and safety of Risankizumab in pediatric patients with medically refractory inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70534
Source records
- crossref · retrieved 2026-09-26T16:46:25.016Z